المؤلفون: van der Westhuizen DP; Division of Ophthalmology, Faculty of Medicine and Health Sciences, Stellenbosch University, PO Box 241, Cape Town, 8000, South Africa. Electronic address: dianvdw@gmail.com., Snyders CI; South African Medical Research Council Centre for Tuberculosis Research, Division of Immunology, Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Stellenbosch University, PO Box 241, Cape Town, 8000, South Africa. Electronic address: cisnyders@sun.ac.za., Kidd M; Centre for Statistical Consultation, Stellenbosch University, Private Bag X1, Matieland, 7602, South Africa. Electronic address: mkidd@sun.ac.za., Walzl G; South African Medical Research Council Centre for Tuberculosis Research, Division of Immunology, Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Stellenbosch University, PO Box 241, Cape Town, 8000, South Africa. Electronic address: gwalzl@sun.ac.za., Chegou NN; South African Medical Research Council Centre for Tuberculosis Research, Division of Immunology, Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Stellenbosch University, PO Box 241, Cape Town, 8000, South Africa. Electronic address: novel@sun.ac.za., Smit DP; Division of Ophthalmology, Faculty of Medicine and Health Sciences, Stellenbosch University, PO Box 241, Cape Town, 8000, South Africa. Electronic address: dpsmit@sun.ac.za.

المصدر: Tuberculosis (Edinburgh, Scotland) [Tuberculosis (Edinb)] 2024 Sep; Vol. 148, pp. 102547. Date of Electronic Publication: 2024 Jul 23.

نوع المنشور: Journal Article; Comparative Study

بيانات الدورية: Publisher: Churchill Livingstone Country of Publication: Scotland NLM ID: 100971555 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-281X (Electronic) Linking ISSN: 14729792 NLM ISO Abbreviation: Tuberculosis (Edinb) Subsets: MEDLINE

مواضيع طبية MeSH: Biomarkers*/urine , Uveitis*/urine , Uveitis*/microbiology , Uveitis*/diagnosis , Tuberculosis, Ocular*/urine , Tuberculosis, Ocular*/diagnosis , HIV Infections*/urine , HIV Infections*/complications, Humans ; Male ; Female ; Adult ; Middle Aged ; Coinfection/urine ; Diagnosis, Differential ; HIV Seropositivity/urine ; HIV Seropositivity/complications ; HIV Seronegativity ; Young Adult ; Predictive Value of Tests ; Urinalysis/methods

المؤلفون: Seto N; Division of General Medicine, Jichi Medical University Saitama Medical Center, Saitama, Japan., Fukuchi T; Division of General Medicine, Jichi Medical University Saitama Medical Center, Saitama, Japan., Kawakami M; Department of Microbiology, Tokyo Metropolitan Institute of Public Health, Tokyo, Japan., Nagashima M; Department of Microbiology, Tokyo Metropolitan Institute of Public Health, Tokyo, Japan., Sadamasu K; Department of Microbiology, Tokyo Metropolitan Institute of Public Health, Tokyo, Japan., Hatakeyama S; Division of Infectious Diseases, Department of Infection and Immunity, Jichi Medical University, Tochigi, Japan; Division of General Medicine, Center for Community Medicine, Jichi Medical University, Tochigi, Japan. Electronic address: hatakeyamas@jichi.ac.jp.

المصدر: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy [J Infect Chemother] 2024 Sep; Vol. 30 (9), pp. 917-921. Date of Electronic Publication: 2024 Feb 06.

نوع المنشور: Case Reports; Journal Article; Review

بيانات الدورية: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 9608375 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1437-7780 (Electronic) Linking ISSN: 1341321X NLM ISO Abbreviation: J Infect Chemother Subsets: MEDLINE

مواضيع طبية MeSH: Pneumonia, Pneumocystis*/diagnosis , Pneumonia, Pneumocystis*/immunology , Pneumonia, Pneumocystis*/microbiology , HIV-1*/immunology , HIV Infections*/complications , HIV Infections*/drug therapy , HIV Infections*/immunology, Humans ; Male ; Middle Aged ; HIV Antibodies/blood ; HIV Antibodies/immunology ; Viral Load ; AIDS-Related Opportunistic Infections/diagnosis ; AIDS-Related Opportunistic Infections/immunology ; AIDS-Related Opportunistic Infections/microbiology ; HIV Seronegativity ; Antibody Formation ; Pneumocystis carinii/isolation & purification ; Pneumocystis carinii/immunology ; East Asian People

المؤلفون: Goga A; HIV and Other Infectious Diseases Research Unit, South African Medical Research Council, Durban, South Africa.; Department of Paediatrics and Child Health, University of Pretoria, Pretoria, South Africa., Ramraj T; HIV and Other Infectious Diseases Research Unit, South African Medical Research Council, Durban, South Africa., Naidoo L; HIV and Other Infectious Diseases Research Unit, South African Medical Research Council, Durban, South Africa., Daniels B; HIV and Other Infectious Diseases Research Unit, South African Medical Research Council, Durban, South Africa., Matlou M; HIV and Other Infectious Diseases Research Unit, South African Medical Research Council, Durban, South Africa., Chetty T; HIV and Other Infectious Diseases Research Unit, South African Medical Research Council, Durban, South Africa., Dassaye R; HIV and Other Infectious Diseases Research Unit, South African Medical Research Council, Durban, South Africa., Ngandu NK; HIV and Other Infectious Diseases Research Unit, South African Medical Research Council, Durban, South Africa., Galli L; Viral Evolution and Transmission Unit, IRCCS Ospedale San Raffaele s.r.l., Milan, Italy., Reddy T; Biostatistics Research Unit, South African Medical Research Council, Durban, South Africa., Seocharan I; Biostatistics Research Unit, South African Medical Research Council, Durban, South Africa., Ndlangamandla Q; Biostatistics Research Unit, South African Medical Research Council, Durban, South Africa., September Q; HIV and Other Infectious Diseases Research Unit, South African Medical Research Council, Durban, South Africa., Ngcobo N; HIV and Other Infectious Diseases Research Unit, South African Medical Research Council, Durban, South Africa., Reddy M; HIV and Other Infectious Diseases Research Unit, South African Medical Research Council, Durban, South Africa., Cafun-Naidoo T; HIV and Other Infectious Diseases Research Unit, South African Medical Research Council, Durban, South Africa., Woeber K; HIV and Other Infectious Diseases Research Unit, South African Medical Research Council, Durban, South Africa., Jeenarain N; HIV and Other Infectious Diseases Research Unit, South African Medical Research Council, Durban, South Africa., Imamdin R; HIV and Other Infectious Diseases Research Unit, South African Medical Research Council, Durban, South Africa., Maharajh K; HIV and Other Infectious Diseases Research Unit, South African Medical Research Council, Durban, South Africa., Ramjeth A; HIV and Other Infectious Diseases Research Unit, South African Medical Research Council, Durban, South Africa., Bhengu T; HIV and Other Infectious Diseases Research Unit, South African Medical Research Council, Durban, South Africa., Clarence E; HIV and Other Infectious Diseases Research Unit, South African Medical Research Council, Durban, South Africa., Van de Perre P; Pathogenesis and Control of Chronic and Emerging Infections, University of Montpellier, INSERM, Etablissement Français du Sang; CHU Montpellier, Montpellier, France., Tylleskär T; Centre for International Health, Department of Global Public Health and Primary Care, University of Bergen, Bergen, Norway., Nagot N; Pathogenesis and Control of Chronic and Emerging Infections, University of Montpellier, INSERM, Etablissement Français du Sang; CHU Montpellier, Montpellier, France., Moles JP; Pathogenesis and Control of Chronic and Emerging Infections, University of Montpellier, INSERM, Etablissement Français du Sang; CHU Montpellier, Montpellier, France., Moore PL; SA MRC Antibody Immunity Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.; Center for HIV and STIs, National Institute for Communicable Diseases a Division of the National Health Laboratory Service, Johannesburg, South Africa.; Centre for the AIDS Programme of Research in South Africa (CAPRISA), Durban, South Africa., Mkhize NN; SA MRC Antibody Immunity Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.; Center for HIV and STIs, National Institute for Communicable Diseases a Division of the National Health Laboratory Service, Johannesburg, South Africa., Gama L; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institute of Health, Bethesda, USA., Dispinseri S; Viral Evolution and Transmission Unit, IRCCS Ospedale San Raffaele s.r.l., Milan, Italy., Biswas P; Viral Evolution and Transmission Unit, IRCCS Ospedale San Raffaele s.r.l., Milan, Italy., Scarlatti G; Viral Evolution and Transmission Unit, IRCCS Ospedale San Raffaele s.r.l., Milan, Italy. scarlatti.gabriella@hsr.it.

مؤلفون مشاركون: PedMAb1 clinical trial team

المصدر: BMC infectious diseases [BMC Infect Dis] 2024 Jul 20; Vol. 24 (1), pp. 712. Date of Electronic Publication: 2024 Jul 20.

نوع المنشور: Clinical Trial Protocol; Journal Article

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 100968551 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2334 (Electronic) Linking ISSN: 14712334 NLM ISO Abbreviation: BMC Infect Dis Subsets: MEDLINE

مواضيع طبية MeSH: HIV Antibodies*/administration & dosage , HIV Infections*/prevention & control , HIV Infections*/drug therapy , HIV Infections*/immunology , HIV Infections*/transmission , HIV-1*/immunology, Female ; Humans ; Infant ; Infant, Newborn ; Male ; Anti-HIV Agents/pharmacokinetics ; Anti-HIV Agents/administration & dosage ; Anti-HIV Agents/therapeutic use ; Antibodies, Monoclonal/pharmacokinetics ; Antibodies, Monoclonal/administration & dosage ; Antibodies, Monoclonal/adverse effects ; Antibodies, Monoclonal/immunology ; Antibodies, Neutralizing/immunology ; Breast Feeding ; Broadly Neutralizing Antibodies/immunology ; Broadly Neutralizing Antibodies/administration & dosage ; Clinical Trials, Phase I as Topic ; Infectious Disease Transmission, Vertical/prevention & control ; Injections, Subcutaneous ; Pre-Exposure Prophylaxis/methods ; Single-Blind Method ; South Africa

المؤلفون: Waalewijn H; Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Cape Town, South Africa.; Department of Pharmacy, Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, The Netherlands., Wasmann RE; Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Cape Town, South Africa., Bamford A; Medical Research Council Clinical Trials Unit, University College London, London, UK.; Infection, Immunity & Inflammation Department, UCL Great Ormond Street Hospital Institute of Child Health, London, UK., Gibb DM; Medical Research Council Clinical Trials Unit, University College London, London, UK., McIlleron HM; Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Cape Town, South Africa.; Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa., Colbers A; Department of Pharmacy, Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, The Netherlands., Burger DM; Department of Pharmacy, Research Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, The Netherlands., Denti P; Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Cape Town, South Africa.

مؤلفون مشاركون: CHAPAS-4 trial team

المصدر: Journal of the Pediatric Infectious Diseases Society [J Pediatric Infect Dis Soc] 2024 Sep 26; Vol. 13 (9), pp. 496-500.

نوع المنشور: Journal Article; Randomized Controlled Trial

بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 101586049 Publication Model: Print Cited Medium: Internet ISSN: 2048-7207 (Electronic) Linking ISSN: 20487193 NLM ISO Abbreviation: J Pediatric Infect Dis Soc Subsets: MEDLINE

مواضيع طبية MeSH: Pyridones*/pharmacokinetics , Heterocyclic Compounds, 3-Ring*/pharmacokinetics , Heterocyclic Compounds, 3-Ring*/therapeutic use , Heterocyclic Compounds, 3-Ring*/blood , Heterocyclic Compounds, 3-Ring*/administration & dosage , Oxazines*/pharmacokinetics , Piperazines*/pharmacokinetics , HIV Infections*/drug therapy , Anti-HIV Agents*/pharmacokinetics , Anti-HIV Agents*/therapeutic use , Anti-HIV Agents*/blood , Anti-HIV Agents*/administration & dosage, Humans ; Child ; Male ; Female ; Tenofovir/pharmacokinetics ; Tenofovir/therapeutic use ; Child, Preschool ; Adolescent ; Emtricitabine/pharmacokinetics ; Emtricitabine/therapeutic use ; Emtricitabine/administration & dosage ; Dideoxynucleosides/pharmacokinetics ; Dideoxynucleosides/therapeutic use ; Dideoxynucleosides/administration & dosage ; Lamivudine/pharmacokinetics ; Lamivudine/therapeutic use ; Lamivudine/administration & dosage ; HIV Integrase Inhibitors/pharmacokinetics ; HIV Integrase Inhibitors/therapeutic use ; HIV Integrase Inhibitors/administration & dosage ; Alanine/pharmacokinetics ; Alanine/analogs & derivatives ; Alanine/therapeutic use ; Biological Availability ; Drug Therapy, Combination ; Zidovudine/pharmacokinetics ; Zidovudine/therapeutic use ; Zidovudine/administration & dosage ; Adenine/analogs & derivatives ; Adenine/pharmacokinetics ; Adenine/therapeutic use ; Drug Interactions

المؤلفون: Bedimo R; Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA., Hardy D; Division of Infectious Diseases, Keck School of Medicine, University of Southern California, Los Angeles, California, USA., Lee D; Owen Clinic, University of California San Diego Health, San Diego, California, USA., Palella F; Infectious Diseases Division, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA., Wohl D; Division of Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.

المصدر: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2024 Sep 20; Vol. 79 (Supplement_2), pp. S63-S75.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Oxford University Press Country of Publication: United States NLM ID: 9203213 Publication Model: Print Cited Medium: Internet ISSN: 1537-6591 (Electronic) Linking ISSN: 10584838 NLM ISO Abbreviation: Clin Infect Dis Subsets: MEDLINE

مواضيع طبية MeSH: Weight Loss* , HIV Infections*/drug therapy , HIV Infections*/complications, Humans ; Anti-HIV Agents/therapeutic use ; HIV Wasting Syndrome/drug therapy ; Consensus

المؤلفون: Bui TI; Department of Pathology & Immunology, Washington University School of Medicine in St. Louis, Saint Louis, Missouri, USA., Farnsworth CW; Department of Pathology & Immunology, Washington University School of Medicine in St. Louis, Saint Louis, Missouri, USA., Anderson NW; Department of Pathology, University Hospitals Health System, Cleveland, Ohio, USA.

المصدر: Journal of clinical microbiology [J Clin Microbiol] 2024 Sep 11; Vol. 62 (9), pp. e0062024. Date of Electronic Publication: 2024 Aug 16.

نوع المنشور: Journal Article; Evaluation Study

بيانات الدورية: Publisher: American Society for Microbiology Country of Publication: United States NLM ID: 7505564 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1098-660X (Electronic) Linking ISSN: 00951137 NLM ISO Abbreviation: J Clin Microbiol Subsets: MEDLINE

مواضيع طبية MeSH: HIV Infections*/diagnosis , HIV Antibodies*/blood , Sensitivity and Specificity* , Point-of-Care Systems*, Humans ; Retrospective Studies ; Male ; Female ; Adult ; Middle Aged ; Young Adult ; Predictive Value of Tests ; Aged ; Adolescent ; Prevalence ; Point-of-Care Testing ; Emergency Service, Hospital ; HIV Testing/methods

المؤلفون: De Nicolò A; Laboratory of Clinical Pharmacology and Pharmacogenetics, Department of Medical Sciences, University of Turin, Turin. Electronic address: amedeo.denicolo@unito.it., Palermiti A; Laboratory of Clinical Pharmacology and Pharmacogenetics, Department of Medical Sciences, University of Turin, Turin., Dispinseri S; Viral Evolution and Transmission Unit, IRCCS Ospedale San Raffaele, Milan., Marchetti G; Clinic of Infectious Diseases, Department of Health Sciences, ASST Santi Paolo e Carlo, University of Milan, Milan., Trunfio M; Unit of Infectious Diseases, Department of Medical Sciences, University of Turin, Turin., De Vivo E; Laboratory of Clinical Pharmacology and Pharmacogenetics, Department of Medical Sciences, University of Turin, Turin., D'Avolio A; Laboratory of Clinical Pharmacology and Pharmacogenetics, Department of Medical Sciences, University of Turin, Turin., Muscatello A; Infectious Diseases Unit, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan., Gori A; Infectious Diseases Unit, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan., Rusconi S; UOC Malattie Infettive, Ospedale Civile di Legnano, ASST Ovest Milanese, Legnano; University of Milan, Milan., Bruzzesi E; Vita-Saluta San Raffaele University, Milan., Gabrieli A; Dipartimento di Scienze Biomediche e Cliniche, Ospedale L Sacco, Milan., Bernasconi DP; Bicocca Bioinformatics Biostatistics and Bioimaging Centre - B4 School of Medicine and Surgery, University of Milano-Bicocca, Monza., Bandera A; University of Milan, Milan., Nozza S; Department of Infectious Diseases, IRCCS Ospedale san Raffaele, Milan, Italy., Calcagno A; Unit of Infectious Diseases, Department of Medical Sciences, University of Turin, Turin.

مؤلفون مشاركون: INACTION (Italian Network of Acute HIV Infection) study group

المصدر: International journal of antimicrobial agents [Int J Antimicrob Agents] 2024 Aug; Vol. 64 (2), pp. 107200. Date of Electronic Publication: 2024 May 18.

نوع المنشور: Journal Article; Randomized Controlled Trial

بيانات الدورية: Publisher: Elsevier Science Publishers Country of Publication: Netherlands NLM ID: 9111860 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-7913 (Electronic) Linking ISSN: 09248579 NLM ISO Abbreviation: Int J Antimicrob Agents Subsets: MEDLINE

مواضيع طبية MeSH: HIV Infections*/drug therapy , HIV Infections*/virology , DNA, Viral*/blood , Leukocytes, Mononuclear*/virology , Lymph Nodes*/virology , Tenofovir*/therapeutic use , Tenofovir*/pharmacokinetics , Tenofovir*/blood, Humans ; Male ; Adult ; Female ; Anti-HIV Agents/therapeutic use ; Anti-HIV Agents/pharmacokinetics ; Anti-HIV Agents/blood ; Oxazines ; Middle Aged ; RNA, Viral/blood ; Plasma/chemistry ; Plasma/virology ; Piperazines/blood ; Emtricitabine/therapeutic use ; Emtricitabine/pharmacokinetics ; Emtricitabine/blood ; Heterocyclic Compounds, 3-Ring/pharmacokinetics ; Heterocyclic Compounds, 3-Ring/therapeutic use ; Heterocyclic Compounds, 3-Ring/blood ; Pyridones/therapeutic use ; Darunavir/therapeutic use ; Darunavir/pharmacokinetics ; Darunavir/blood ; HIV-1/drug effects ; Viral Load ; Alanine/blood ; Anti-Retroviral Agents/therapeutic use ; Anti-Retroviral Agents/pharmacokinetics ; Anti-Retroviral Agents/blood

المؤلفون: Sehurutshi A; Division of Epidemiology and Biostatistics, Stellenbosch University, Cape Town, South Africa.; Harvard AIDS Institute Partnership, Gaberone, Botswana., Farooqui H; Department of Population Medicine, College of Medicine, QU Health, Qatar University, P.O. Box 2713, Doha, Qatar., Chivese T; Department of Population Medicine, College of Medicine, QU Health, Qatar University, P.O. Box 2713, Doha, Qatar. tchivese@qu.edu.qa.

المصدر: AIDS and behavior [AIDS Behav] 2024 Aug; Vol. 28 (8), pp. 2630-2638. Date of Electronic Publication: 2024 Jun 10.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Springer Science + Business Media Country of Publication: United States NLM ID: 9712133 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-3254 (Electronic) Linking ISSN: 10907165 NLM ISO Abbreviation: AIDS Behav Subsets: MEDLINE

مواضيع طبية MeSH: COVID-19*/epidemiology , COVID-19*/prevention & control , HIV Infections*/epidemiology , Interrupted Time Series Analysis* , SARS-CoV-2*, Humans ; Botswana/epidemiology ; Male ; Female ; Adult ; Middle Aged ; HIV Testing/statistics & numerical data ; Young Adult ; Anti-HIV Agents/therapeutic use ; Pandemics

المؤلفون: Laufer NL; Departamento de Microbiología, Parasitología e Inmunología, Facultad de Medicina, Universidad de Buenos Aires, Buenos Aires, Argentina., Bouzas MB; Hospital Muñiz, Ciudad de Buenos Aires, Argentina., Fernández Giuliano S; Hospital Muñiz, Ciudad de Buenos Aires, Argentina., Zapiola I; Hospital Muñiz, Ciudad de Buenos Aires, Argentina., Mammana L; Hospital Muñiz, Ciudad de Buenos Aires, Argentina., Salomon H; Departamento de Microbiología, Parasitología e Inmunología, Facultad de Medicina, Universidad de Buenos Aires, Buenos Aires, Argentina., Monzani C; Departamento de Microbiología, Parasitología e Inmunología, Facultad de Medicina, Universidad de Buenos Aires, Buenos Aires, Argentina., Castro G; Laboratorio Central de Córdoba, Ciudad de Córdoba, Argentina., Suarez Ornani ML; Dirección de Respuesta al VIH, ITS, Hepatitis Virales y Tuberculosis, Ministerio de Salud de la Nación, Ciudad de Buenos Aires, Argentina., Rojas Machado P; Dirección de Respuesta al VIH, ITS, Hepatitis Virales y Tuberculosis, Ministerio de Salud de la Nación, Ciudad de Buenos Aires, Argentina., Cochon N; Dirección de Respuesta al VIH, ITS, Hepatitis Virales y Tuberculosis, Ministerio de Salud de la Nación, Ciudad de Buenos Aires, Argentina., Adazsko A; Dirección de Respuesta al VIH, ITS, Hepatitis Virales y Tuberculosis, Ministerio de Salud de la Nación, Ciudad de Buenos Aires, Argentina., Ravasi G; Pan American Health Organization, Washington, District of Columbia, USA., Vila M; Pan American Health Organization, Ciudad de Buenos Aires, Argentina., Maulen S; Dirección de Respuesta al VIH, ITS, Hepatitis Virales y Tuberculosis, Ministerio de Salud de la Nación, Ciudad de Buenos Aires, Argentina., Ceriotto M; Dirección de Respuesta al VIH, ITS, Hepatitis Virales y Tuberculosis, Ministerio de Salud de la Nación, Ciudad de Buenos Aires, Argentina., Barbas MG; Laboratorio Central de Córdoba, Ciudad de Córdoba, Argentina., Martini S; Dirección de Respuesta al VIH, ITS, Hepatitis Virales y Tuberculosis, Ministerio de Salud de la Nación, Ciudad de Buenos Aires, Argentina.

المصدر: AIDS research and human retroviruses [AIDS Res Hum Retroviruses] 2024 Aug; Vol. 40 (8), pp. 464-470. Date of Electronic Publication: 2024 Apr 03.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Mary Ann Liebert Country of Publication: United States NLM ID: 8709376 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1931-8405 (Electronic) Linking ISSN: 08892229 NLM ISO Abbreviation: AIDS Res Hum Retroviruses Subsets: MEDLINE

مواضيع طبية MeSH: Drug Resistance, Viral*/genetics , HIV-1*/genetics , HIV-1*/drug effects , HIV Infections*/drug therapy , HIV Infections*/epidemiology , HIV Infections*/virology , World Health Organization*, Humans ; Argentina/epidemiology ; Male ; Cross-Sectional Studies ; Female ; Adult ; Middle Aged ; Prevalence ; Young Adult ; Adolescent ; Anti-HIV Agents/therapeutic use ; Anti-HIV Agents/pharmacology ; Mutation ; Reverse Transcriptase Inhibitors/therapeutic use ; Reverse Transcriptase Inhibitors/pharmacology ; Aged

المؤلفون: Stolbova EA; Department of Bioinformatics, Institute of Biomedical Chemistry, 10-7, Pogodinskaya Street, Moscow 119121, Russia., Stolbov LA; Department of Bioinformatics, Institute of Biomedical Chemistry, 10-7, Pogodinskaya Street, Moscow 119121, Russia., Filimonov DA; Department of Bioinformatics, Institute of Biomedical Chemistry, 10-7, Pogodinskaya Street, Moscow 119121, Russia., Poroikov VV; Department of Bioinformatics, Institute of Biomedical Chemistry, 10-7, Pogodinskaya Street, Moscow 119121, Russia., Tarasova OA; Department of Bioinformatics, Institute of Biomedical Chemistry, 10-7, Pogodinskaya Street, Moscow 119121, Russia.

المصدر: Viruses [Viruses] 2024 Jul 15; Vol. 16 (7). Date of Electronic Publication: 2024 Jul 15.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: MDPI Country of Publication: Switzerland NLM ID: 101509722 Publication Model: Electronic Cited Medium: Internet ISSN: 1999-4915 (Electronic) Linking ISSN: 19994915 NLM ISO Abbreviation: Viruses Subsets: MEDLINE

مواضيع طبية MeSH: HIV-1*/drug effects , HIV-1*/genetics , Drug Resistance, Viral*/genetics , HIV Infections*/virology , HIV Infections*/drug therapy , HIV Protease*/genetics , HIV Protease*/metabolism , HIV Protease Inhibitors*/pharmacology , HIV Protease Inhibitors*/therapeutic use, Humans ; Amino Acid Sequence ; Anti-HIV Agents/pharmacology ; Anti-HIV Agents/therapeutic use